Trials / Completed
CompletedNCT00212641
A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus
Randomized Double-Blind Placebo-Controlled Pharmacodynamic Evaluation of ONO-5129 in Patients With Treatment Naive Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 105 (planned)
- Sponsor
- Ono Pharma USA Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to characterize the pharmacodynamic profile, safety and tolerability of ONO-5129 in patients with Type 2 Diabetes mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-5129 |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2007-10-01
- First posted
- 2005-09-21
- Last updated
- 2012-10-11
Locations
67 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00212641. Inclusion in this directory is not an endorsement.